Updated October 9 at 6:09pm
45 results total, viewing 11 - 20
(Updated, 5:40 p.m.) Ximedica announced Tuesday it has purchased the San Francisco-based Bridge Design, providing the Rhode Island-based medical technology development company with a West Coast hub. more
Tivorsan Pharmaceuticals Inc. has named James E. Connolly CEO. The biotechnology company, which focuses on treating Duchenne Muscular Dystrophy and other neuromuscular disorders, also said that Connolly will serve as a member of its board. more
The Top 5 Biotechnology & Life Sciences Companies, ranked by number of local employees. more
The first two patients in IlluminOss Medical Inc.’s U.S. Lightfix clinical trial for the treatment of impending and pathologic fractures have been successfully treated at the Marshall University Joan C. Edwards School of Medicine. more
PROVIDENCE — The elements of a mixed-use project that could cover five acres of the former Interstate 195 land were revealed last week in a public overview by the development team. The project, a joint effort of CV Properties LLC of … more
The Defense Threat Reduction Agency is investing $5.2 million for the development of a new type of vaccine against Q fever, and a local company is involved in the effort. more
To Amgen Inc.'s Senior Manager for Manufacturing Jimmy Fleming, the task of ensuring that he and his team are producing a quality product is of the utmost importance – professionally and personally. Fleming's sister is one of the more … more
ProThera Biologics has appointed Denice M. Spero as president and chief business officer. more
Medrobotics Corp. was named a “rising star” in the Smaller Business Association of New England Inc.’s 2015 New England Innovation Awards. more
A smart wristband invented by University of Rhode Island students to monitor Parkinson’s disease was a finalist in a recent international design competition. more
« Prev | 1 | 2 | 3 | 4 | 5 Next »